Clinical trial
Safety and Antipyretic Efficacy of Acetaminophen in the Febrile Intensive Care Unit Patient.
NCT02280239 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Antipyretic Efficacy of Acetaminophen in the Febrile Intensive Care Unit Patient.
- Lead sponsor
- University of British Columbia
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- May 31, 2015
- Completion date
- February 29, 2016
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.